Pharmacogenetics and Genomics

Papers
(The TQCC of Pharmacogenetics and Genomics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-1969
PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics23
Knowledge, attitude, and practice towards pharmacogenomics among hospital pharmacists in Thailand15
Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms14
Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis13
Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia11
Cost-effectiveness analysis of pretreatment screening for NUDT15 defective alleles11
Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry10
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators10
HLA-B*58:01 association in allopurinol-induced severe cutaneous adverse reactions: the implication of ethnicity and clinical phenotypes in multiethnic Malaysia9
Regulation of CYP3A4 and CYP3A5 by a lncRNA: a potential underlying mechanism explaining the association between CYP3A4*1G and CYP3A metabolism9
Patient insights on features of an effective pharmacogenomics patient portal9
Effects of CYP2C19, CYP2C9 and CYP3A4 gene polymorphisms on plasma voriconazole levels in Chinese pediatric patients8
Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients8
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria8
Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine8
Identification of high-impact gene–drug pairs for pharmacogenetic testing in Alberta, Canada7
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia7
Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance6
Histone acetylation at the sulfotransferase 1a1 gene is associated with its hepatic expression in normal aging6
Incorporating G6PD genotyping to identify patients with G6PD deficiency6
The effect of SLC6A3 variable number of tandem repeats and methylation levels on individual susceptibility to start tobacco smoking and on the ability of smokers to quit smoking6
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinica5
Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients5
JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity5
Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation5
C677T and A1298C MTHFR gene polymorphisms and response to fluoropyrimidine-based chemotherapy in Mestizo patients with metastatic colorectal cancer5
Analytical validation of a laboratory-development multigene pharmacogenetic assay4
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity4
Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis4
Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon4
Single Nucleotide Polymorphisms (SNPs) in PRKG1 & SPATA13-AS1 are associated with bronchodilator response: a pilot study during acute asthma exacerbations in African American children4
Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma4
Implementation of pharmacogenomics into inpatient general medicine4
HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B*57:01 genotyping to predict abacavir hypersensitivity reaction in Spain4
0.046019077301025